Necker Hospital – Department of Adult Hematology

Weekly

A dedicated committee for CAR-T cell therapy indications is in place, involving the cell therapy department, pharmacists, referring physicians, and coordinators from both sites, with information shared with the intensive care units.

This tumor board is linked to the allogeneic transplantation committee, which meets separately from the multidisciplinary boards and determines indications for transplantation and CAR-T therapy.

Twice Monthly

A meeting is held with the onco-geriatric specialists every two weeks with Dr. Cécile Bally, Dr. Clarisse Cazelles, and Dr. Clémence Loiseau.

See the tumor boards for rare diseases within the national reference centers (Adult hereditary immunodeficiencies – monthly, CELAC – monthly, Mastocytosis – monthly):

In addition, as both departments coordinate several national reference centers, national tumor boards are organized and led by physicians from both services for:

• adult hereditary immunodeficiencies (F. Suarez, M. Cheminant, D. Boutboul),
• Castleman disease (D. Boutboul),
• Mastocytosis (J. Rossignol and O. Hermine),
• lymphoproliferative disorders associated with celiac disease (M. Cheminant, C. Loiseau, and O. Hermine),
• NKT lymphomas (O. Hermine).

When necessary for patient management, some physicians from the department also participate in other national tumor boards (sickle cell disease, aplastic anemia, neutropenias, myeloproliferative neoplasms, cerebral and ocular lymphomas, etc.)

Twice Monthly

At both the Necker and Cochin sites, a bi-monthly hemostasis tumor board is organized (Drs. C. Bally and L. Frenzel at Necker, and Prof. M. Fontenay at Cochin) together with the hemostasis laboratories from both sites.